Emmaus Life Sciences appoints Ian Zwicker and Dr. Seah Lim to Board; Lim loans $1.2M

Emmaus Life Sciences, Inc.

Ian Zwicker appointed to Board and as Chair of Audit Committee; will receive $25,000 for audit committee service.
Dr. Seah Lim appointed to fill Board vacancy; brings expertise in hematology, oncology, and sickle cell disease.
Dr. Lim loaned Emmaus $1.2M at 6% interest, due in 3 years, with one restricted share per $5 principal.
Loan proceeds used to augment working capital and for general corporate purposes.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Ian Zwicker

Director and Chair of Audit Committee

EMMA · Emmaus Life Sciences, Inc.

Effective: 2022-10-04
Filed: October 6, 2022, 7:59 PM ET

the Board appointed Ian Zwicker as a director of the company and as the Chair and sole member of the Audit Committee

Appointed

Seah H. Lim

Director

EMMA · Emmaus Life Sciences, Inc.

Effective: 2022-10-04
Filed: October 6, 2022, 7:59 PM ET

The Board also appointed Seah H. Lim, M.D., Ph.D. as a director to fill a vacancy on the five-person Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ian Zwicker was appointed as Director and Chair of Audit Committee at Emmaus Life Sciences, Inc..

Action: appointed
Role: Director and Chair of Audit Committee

Exact text from the filing

the Board appointed Ian Zwicker as a director of the company and as the Chair and sole member of the Audit Committee

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Seah H. Lim was appointed as Director at Emmaus Life Sciences, Inc..

Action: appointed
Role: Director

Exact text from the filing

The Board also appointed Seah H. Lim, M.D., Ph.D. as a director to fill a vacancy on the five-person Board.

View on SEC.gov

Emmaus Life Sciences, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-22-062300

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.